U.S. Agrees To $231M Deal For At-Home Test Kits

The Biden administration has secured a $231 million deal with an Australian company to produce rapid COVID-19 test kits that allow home testing with results in 20 minutes. These tests, recently approved by US regulators, are the only ones available without a prescription. The ability to quickly test, trace, and quarantine is crucial to the national strategy for containing the virus. The company plans to use the funds to establish a US manufacturing plant and deliver 8.5 million tests for federal use, although no specific timeline has been provided.

What is the value of the deal the Biden administration agreed to for producing COVID-19 test kits?

• $100 million

• $231 million

• $500 million

• $1 billion

What is unique about the COVID-19 test kits mentioned in the transcript?

• They can be used at home without a prescription.

• They are the cheapest tests available.

• They are the fastest tests available.

• They require a doctor's prescription.

Why is rapid testing considered a linchpin of the national strategy?

• It requires less manpower.

• It allows for quick contact tracing and quarantine.

• It is the most expensive method.

• It is the only method available.

What will the company do with the funds from the deal?

• Invest in research and development.

• Build a US manufacturing plant.

• Expand its workforce.

• Purchase new technology.

How many test kits will the company deliver for federal use?

• 12 million

• 8.5 million

• 10 million

• 5 million